<DOC>
	<DOCNO>NCT01647828</DOCNO>
	<brief_summary>The study consist Phase1b lead-in portion determine maximum tolerate dose ( MTD ) OMP-59R5 combination nab-paclitaxel gemcitabine follow Phase 2 , multicenter , randomize , placebo-controlled portion evaluate efficacy safety OMP-59R5 combination nab-paclitaxel gemcitabine subject previously untreated stage IV pancreatic cancer .</brief_summary>
	<brief_title>A Phase 1b/2 Study OMP-59R5 Combination With Nab-Paclitaxel Gemcitabine Subjects With Previously Untreated Stage IV Pancreatic Cancer</brief_title>
	<detailed_description />
	<mesh_term>Pancreatic Neoplasms</mesh_term>
	<mesh_term>Paclitaxel</mesh_term>
	<mesh_term>Gemcitabine</mesh_term>
	<mesh_term>Albumin-Bound Paclitaxel</mesh_term>
	<criteria>Subjects must meet follow major inclusion criterion eligible study : 1 . 18 year age old 2 . Histologically cytologically document stage IV ductal adenocarcinoma pancreas . 3 . Performance Status ( ECOG ) 0 1 4 . FFPE tumor tissue metastatic site ( 5 . Adequate organ function 6 . Written consent IRB/IECapproved Informed Consent Form prior studyspecific evaluation . 7 . For woman childbearing potential , negative serum pregnancy test screening use physicianapproved method birth control 30 day prior first study drug administration 30 day follow last study drug administration . 8 . Male subject must surgically sterile must agree use physicianapproved contraception 30 day prior first study drug administration 30 day follow last study drug administration . Subjects meet follow major exclusion criterion eligible participation study : 1 . Neuroendocrine tumor ( i.e. , carcinoid , islet cell cancer ) pancreas . 2 . Known brain metastasis . 3 . Prior therapy , include systemic therapy , surgical resection radiation newly diagnose stage IV pancreatic cancer . 4 . Presence serious unstable concomitant systemic disorder incompatible clinical study ( e.g. , substance abuse , uncontrolled intercurrent illness include active infection , arterial thrombosis , symptomatic pulmonary embolism ) . 5 . Any disorder would significantly compromise protocol compliance . 6 . Prior nonpancreatic malignancy treat chemotherapy . Prior malignancy treat surgery and/or radiotherapy alone must remission â‰¥3 year . The following prior malignancy allowable irrespective occur : situ carcinoma cervix , situ ductal breast cancer , lowgrade local bladder cancer , nonmelanotic skin cancer . 7 . Known human immunodeficiency virus ( HIV ) infection . 8 . Females pregnant breastfeeding .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Newly diagnose Stage IV Pancreatic Cancer</keyword>
</DOC>